CD8A and neoplasm: Intratumoral injections with Ac53FaxNeu5Ac resulted in reduced tumor growth, enhanced infiltration of CD8+ T cells and NK cells, reduced infiltration of regulatory immune cells leading to enhanced tumor cell killing by CD8+ T cells.